Genetic study for inherited auditory neuropathy hearing loss
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This study looks at a specific genetic cause of hearing loss called OTOF-related auditory neuropathy. If you have this condition, researchers will test your DNA to learn more about it, which may help with future diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have hearing loss that was present from birth or early childhood.
- You have been diagnosed with auditory neuropathy spectrum disorder (ANSD) – a type of hearing loss where sound reaches the ear but the signal is not sent properly to the brain.
- Your hearing test (ABR) shows missing or abnormal brain wave responses, and other tests (OAE or CM) show that the inner ear works, which points to ANSD.
- You have no known cause for the hearing loss, such as premature birth, low oxygen, severe jaundice, or a known syndrome.
- You have not had cochlear implants in both ears, and there is no structural problem in your inner ear or hearing nerve.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children with hearing loss caused by changes in specific genes (GJB2 or OTOF). It helps researchers understand how hearing develops over time and how children may do with or without cochlear implants.
This study follows people with hearing loss caused by changes (mutations) in the otoferlin gene to better understand how hearing and hearing-related test results change over time. It may help researchers prepare for future treatments by building a clear picture of the natural course of the condition.
This study builds a patient registry and tracks the natural history of hearing loss in people whose genetic test shows changes in the otoferlin (OTOF) gene. It may help researchers understand how hearing symptoms progress over time and improve future treatments.
This study looks for genetic causes of hearing loss in babies who did not pass their newborn hearing screening. It aims to help families understand why their child has hearing loss and may guide future care.
This study follows people and families with autosomal dominant inherited hearing loss to better understand how it progresses. It may help researchers learn what to expect over time and guide future treatment planning.
This trial tests a gene therapy called EH002 for people with severe or profound hearing loss due to changes in the OTOF gene. The treatment aims to help the ear hear better by replacing the faulty gene.
Hear when a new Auditory Neuropathy Spectrum Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.